The role of nipple-aspirate fluid cytology in breast-cancer risk screening.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Publication Year:
      2009
    • Subject Terms:
    • NAICS/Industry Codes:
      NAICS/Industry Codes 923120 Administration of Public Health Programs
      621999 All Other Miscellaneous Ambulatory Health Care Services
    • Abstract:
      The article focuses on the relevance of nipple-aspirate fluid (NAF) cytology in the screening of breast-cancer in the U.S. Multiple long-term studies are believed to have pertinently evidenced that atypical epithelial cells in cytology specimens, including NAF and fine-needle aspiration (FNA), can potentially contribute to the risk of developing breast cancer. The traditional preventive approaches, on the other hand, are believed not truly effective in assessing breast-cancer risk.
    • ISSN:
      05807247
    • Accession Number:
      37034817
  • Citations
    • ABNT:
      BENTZ, J. The role of nipple-aspirate fluid cytology in breast-cancer risk screening. MLO: Medical Laboratory Observer, [s. l.], v. 41, n. 3, p. 10, 2009. Disponível em: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edb&AN=37034817. Acesso em: 25 out. 2020.
    • AMA:
      Bentz J. The role of nipple-aspirate fluid cytology in breast-cancer risk screening. MLO: Medical Laboratory Observer. 2009;41(3):10. Accessed October 25, 2020. http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edb&AN=37034817
    • APA:
      Bentz, J. (2009). The role of nipple-aspirate fluid cytology in breast-cancer risk screening. MLO: Medical Laboratory Observer, 41(3), 10.
    • Chicago/Turabian: Author-Date:
      Bentz, Joel. 2009. “The Role of Nipple-Aspirate Fluid Cytology in Breast-Cancer Risk Screening.” MLO: Medical Laboratory Observer 41 (3): 10. http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edb&AN=37034817.
    • Harvard:
      Bentz, J. (2009) ‘The role of nipple-aspirate fluid cytology in breast-cancer risk screening’, MLO: Medical Laboratory Observer, 41(3), p. 10. Available at: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edb&AN=37034817 (Accessed: 25 October 2020).
    • Harvard: Australian:
      Bentz, J 2009, ‘The role of nipple-aspirate fluid cytology in breast-cancer risk screening’, MLO: Medical Laboratory Observer, vol. 41, no. 3, p. 10, viewed 25 October 2020, .
    • MLA:
      Bentz, Joel. “The Role of Nipple-Aspirate Fluid Cytology in Breast-Cancer Risk Screening.” MLO: Medical Laboratory Observer, vol. 41, no. 3, Mar. 2009, p. 10. EBSCOhost, search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edb&AN=37034817.
    • Chicago/Turabian: Humanities:
      Bentz, Joel. “The Role of Nipple-Aspirate Fluid Cytology in Breast-Cancer Risk Screening.” MLO: Medical Laboratory Observer 41, no. 3 (March 2009): 10. http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edb&AN=37034817.
    • Vancouver/ICMJE:
      Bentz J. The role of nipple-aspirate fluid cytology in breast-cancer risk screening. MLO: Medical Laboratory Observer [Internet]. 2009 Mar [cited 2020 Oct 25];41(3):10. Available from: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edb&AN=37034817